Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Axsome
Biotech
Psychiatry biotech hopes to Transcend PTSD rivals with new data
Transcend Therapeutics's MDMA analog treatment for patients with PTSD displayed rapid and durable effects in a small, open-label trial.
Max Bayer
Dec 5, 2023 5:45pm
Neumora installs new CEO ahead of pivotal depression trials
Jul 18, 2023 6:30am
Arrivo's depression med flunks ph. 2, shows benefit for women
Oct 17, 2022 12:38pm
Axsome posts positive phase 3 data for depression drug
May 31, 2022 10:41am
FDA rejects Axsome’s migraine med, but issues are 'addressable'
May 2, 2022 4:21pm
Another setback for Axsome as migraine med headed for FDA no
Apr 25, 2022 1:24pm